{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:04:08Z","timestamp":1793016248426,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SPR\/2020\/00315"],"award-info":[{"award-number":["SPR\/2020\/00315"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jceh.2025.102559","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:02:51Z","timestamp":1744135371000},"page":"102559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Liver-related Events and Outcomes in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease Varies With the Type of Cardiometabolic Risk Factor"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-6846","authenticated-orcid":false,"given":"Shekhar","family":"Swaroop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-4921","authenticated-orcid":false,"given":"Sagnik","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnav","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umang","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samagra","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitkumar","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baibaswata","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-437X","authenticated-orcid":false,"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.102559_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2025.102559_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.102559_bib3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.102559_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3350\/cmh.2024.0140","article-title":"Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): insights into regional and ethnic differences","volume":"30","author":"Oh","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2025.102559_bib5","first-page":"370","article-title":"Clinical outcomes in biopsy-proven nonalcoholic fatty liver disease patients: a multicenter registry-based cohort study","volume":"21","author":"Fujii","year":"2023","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jceh.2025.102559_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep4.1831","article-title":"Community socioeconomic deprivation predicts nonalcoholic steatohepatitis","volume":"6","author":"Giammarino","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2025.102559_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.102559_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010214","article-title":"Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2025.102559_bib9","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.jhep.2023.09.030","article-title":"The influence of different combinations of cardiometabolic risk factors on the prevalence of MASLD and risk of advanced fibrosis deserves attention","volume":"80","author":"Yang","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.102559_bib10","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2337\/dc23-1937","article-title":"Metabolic syndrome traits increase the risk of major adverse liver outcomes in type 2 diabetes","volume":"47","author":"Shang","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2025.102559_bib11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4103\/2230-8210.122606","article-title":"Imaging of non alcoholic fatty liver disease: a road less travelled","volume":"17","author":"Singh","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jceh.2025.102559_bib12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.102559_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiol.2020191152","article-title":"Assessment of hepatic steatosis in nonalcoholic fatty liver disease by using quantitative US","volume":"295","author":"Han","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2025.102559_bib14","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.102559_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3350\/cmh.2020.0067","article-title":"Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH","volume":"26","author":"Hydes","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2025.102559_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 renewing consensus in portal hypertension","volume":"76","author":"De Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.102559_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2024.05.008","article-title":"Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD","volume":"81","author":"Gawrieh","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.102559_bib18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jceh.2025.102559_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","article-title":"Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study","volume":"165","author":"Huang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.102559_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.102559_bib21","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/liv.16016","article-title":"The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes","volume":"44","author":"Riley","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.102559_bib22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41366-023-01346-w","article-title":"Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD","volume":"47","author":"De","year":"2023","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jceh.2025.102559_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12072-022-10436-2","article-title":"Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United States","volume":"17","author":"Dao","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.102559_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/03007995.2023.2279676","article-title":"The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis","volume":"40","author":"Shinde","year":"2024","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jceh.2025.102559_bib25","article-title":"Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD","volume":"6","author":"Akbari","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2025.102559_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/jgh.15787","article-title":"Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease","volume":"37","author":"Chan","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.102559_bib27","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.102559_bib28","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1007\/s10620-023-08085-y","article-title":"Poor performance of non-invasive tests for advanced fibrosis in nonalcoholic fatty liver disease: a multicentric asian study","volume":"68","author":"Arora","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2025.102559_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12876-024-03449-8","article-title":"Evaluating the efficacy of 8 non-invasive models in predicting MASLD and progression: a prospective study","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2025.102559_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.jceh.2025.102559_bib31","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.2024.1447","article-title":"Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease","volume":"331","author":"Lin","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2025.102559_bib32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2468-1253(23)00141-3","article-title":"Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis","volume":"8","author":"M\u00f3zes","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:49:23Z","timestamp":1757771363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0973688325000593"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.102559","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver-related Events and Outcomes in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease Varies With the Type of Cardiometabolic Risk Factor","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.102559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102559"}}